Six years after it began working on its flagship SKi Pro technology, a small San Diego-based proteomics firm recently launched it and is now exploring the next phase of its business strategy: using the platform to develop diagnostic tools.
Silicon Kinetics, a 12-employee company, last month announced an agreement with SAIC-Frederick to evaluate the SKi Pro platform for possible adoption by the National Cancer Institute contractor. The platform debuted in June.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.